Prescribe or Pass: The PoP Pod
Prescribe or Pass: The PoP Pod is the clinician edition of Prescribe or Pass an evidence-based podcast for pharmacists, pharmacy students and other clinicians who work with medicines.
Hosted by Australian pharmacist, educator and science communicator Kate Thomas, each episode explores one medicine, one condition or one clinical concept, explaining not just what we do, but why we do it.
Expect practical pharmacology, clinical reasoning, patient counselling, common misconceptions, adverse effects, ethical reflection and the questions that arise in real-world practice.
Some episodes stand alone. Others form structured educational series, with reflective questions to support continuing professional development.
Clear, practical and independent, PoP Pod helps clinicians build confidence, challenge assumptions and communicate medicines information more effectively.
Prescribe or Pass: The PoP Pod
Understanding Methylphenidate: How It Works, What to Expect and What to Monitor
Use Left/Right to seek, Home/End to jump to start or end. Hold shift to jump forward or backward.
Methylphenidate is one of the most commonly used medicines for ADHD, but understanding it requires more than knowing a list of brand names.
In this episode of Prescribe or Pass: The PoP Pod, pharmacist Kate Thomas explains how methylphenidate works, why immediate-release and modified-release products behave differently, and what patients may realistically notice when treatment is effective.
She also covers common adverse effects, including reduced appetite and sleep disturbance, practical counselling points, and the monitoring that should accompany treatment.
By the end of the episode, you should have a clearer understanding of:
• how methylphenidate affects dopamine and noradrenaline signalling
• the difference between immediate-release and modified-release treatment
• what a useful clinical response may look like
• how to counsel about appetite, sleep and dosing
• what should be monitored during treatment
The episode finishes with reflective questions and suggested wording to support pharmacists documenting their continuing professional development.
This is Episode 3 of an eight-part series on ADHD medicines. Next, we compare the different methylphenidate formulations and why products containing the same active ingredient may not feel the same in practice.